Arbe Robotics grants 120,000 options to director

A director of Arbe Robotics received 120,000 stock options with long-dated vesting and an exercise price of $0.7045 under a Rule 10b5-1 plan.

Rhea-AI Filing Summary

Arbe Robotics Ltd. (ARBE) reported that director Eugene Scott Crist received a grant of 120,000 stock options on September 9, 2026 under the company’s 2021 Share Incentive Plan. The options have an exercise price of $0.7045 per share, expire on September 9, 2036, and are currently held as a direct derivative position.

According to the grant terms, the options vest in twelve equal three‑month installments starting on December 9, 2026, contingent on Mr. Crist’s continued service with Arbe Robotics or its subsidiaries through each vesting date. The filing indicates the transaction was made under a Rule 10b5-1 trading plan.

Insider Trade Summary 10b5-1

Grant/Award: 120,000 shares

Grant/Award 1 txn

Insider CRIST EUGENE SCOTT

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options F1	120,000	$0.00	$0.00

Holdings After Transaction: Stock Options — 120,000 contracts (Direct)

Footnotes (1)

1. F1. Stock options were granted on September 9, 2026 under the Company's 2021 Share Incentive Plan, with the options vesting in twelve equal three-month installments commencing December 9, 2026, subject to the Reporting Person's continued service to the Issuer or its subsidiaries through each vesting date.

Key Figures

Stock options granted: 120,000 options Exercise price: $0.7045 per share Expiration date: September 9, 2036 +3 more

6 metrics

Stock options granted 120,000 options Grant to director on September 9, 2026 under 2021 Share Incentive Plan

Exercise price $0.7045 per share Exercise price for the 120,000 granted stock options

Expiration date September 9, 2036 Option expiration for the 120,000 stock options

Underlying Ordinary Shares 120,000 shares Shares underlying the granted stock options

Vesting installments 12 installments Options vest in twelve equal three‑month installments

Vesting start date December 9, 2026 First vesting date for the stock options, subject to continued service

Key Terms

Rule 10b5-1 trading plan, 2021 Share Incentive Plan, vesting, Ordinary Shares

4 terms

Rule 10b5-1 trading plan regulatory

"The filing indicates the transaction was made under a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

2021 Share Incentive Plan financial

"granted on September 9, 2026 under the Company's 2021 Share Incentive Plan"

vesting financial

"with the options vesting in twelve equal three-month installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARBE disclose for director Eugene Scott Crist?

Arbe Robotics disclosed that director Eugene Scott Crist was granted 120,000 stock options on September 9, 2026 under the 2021 Share Incentive Plan, with an exercise price of $0.7045 per share and expiration on September 9, 2036.

What are the vesting terms of the 120,000 stock options granted by ARBE?

The 120,000 stock options vest in twelve equal three‑month installments starting on December 9, 2026. Vesting is conditioned on the reporting person’s continued service to Arbe Robotics Ltd. or its subsidiaries through each vesting date.

What is the exercise price of the new stock options granted by ARBE (ticker ARBE)?

The stock options granted to the director have an exercise price of $0.7045 per Ordinary Share. Each option is exercisable into one Ordinary Share of Arbe Robotics, subject to vesting and the stated expiration date of September 9, 2036.

When do the newly granted ARBE options expire?

The stock options granted to the director expire on September 9, 2036. They may be exercised into Ordinary Shares at an exercise price of $0.7045 per share, subject to the twelve-installment vesting schedule beginning December 9, 2026.

Were the ARBE insider transactions made under a Rule 10b5-1 plan?

Yes. The filing indicates the transactions were made under a Rule 10b5-1 trading plan, as reflected by the document-level Rule 10b5-1 checkbox being affirmed for this Form 4.

How many ARBE options does the director hold after this reported grant?

After the reported grant, the director is shown as directly holding 120,000 stock options related to Arbe Robotics Ltd., corresponding to 120,000 underlying Ordinary Shares, subject to vesting and the option terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:30 PM Accepted by SEC EDGAR 09/15/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CRIST EUGENE SCOTT

(Last) (First) (Middle)

C/O ARBE ROBOTICS LTD.

HAHASHMONAIM ST. 107

(Street)

TEL AVIV 000000

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arbe Robotics Ltd. [ ARBE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$0.7045	09/09/2026		A		120,000		(1)	09/09/2036	Ordinary Shares	120,000	$0	120,000	D

Explanation of Responses:

1. Stock options were granted on September 9, 2026 under the Company's 2021 Share Incentive Plan, with the options vesting in twelve equal three-month installments commencing December 9, 2026, subject to the Reporting Person's continued service to the Issuer or its subsidiaries through each vesting date.

	/s/ Crist Eugene Scott	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)